Why do histopathology consultations still start with a box of glass slides?
A professional reading of glass-slide shipping in 2026, and what it reveals about second opinions, LIS integration, and digital consultation pathways.
AI reads breast cancer lymph node metastases in a way closer to pathologist practice
A Scientific Reports study describes a model that combines nuclear features with tissue context to detect breast cancer lymph node metastases,…
Connecting structured pathology reports to PACS: why the Fujifilm and mTuitive agreement matters to pathologists
The Fujifilm and mTuitive agreement connects structured pathology reports to Synapse Pathology through the LIS, with direct implications for…
AstraZeneca and Roche partner to support digital pathology in breast and lung cancer across Asia
A professional analysis of the AstraZeneca and Roche partnership in Asia, and what it means for pathologists working with HER2, TROP2, and…
WSI algorithms before the FDA: four clearances map a practical path for digital pathology
A practical reading of FDA pathways for WSI algorithms: Paige, ArteraAI, Galen, and Genius, and what they mean for digital pathology inside the lab.
From tissue signal to treatment decision: where do AI tools break down?
A pathology-focused reading of the gap between AI and spatial biology signals and usable clinical decisions.
Tissue detection algorithms in scanners: where do labs lose time and storage?
A practical reading of a new study on how tissue detection algorithms in whole-slide scanners affect scan area, turnaround time, and file size.
Multicenter evidence: digital pathology matches light microscopy in histopathology reporting
A Histopathology study of 2,024 cases compares digital pathology with light microscopy in routine reporting and cancer screening samples, with…
Aira Matrix algorithms inside Fusion AP: a small announcement with a large workflow question
A practical reading of Techcyte’s announcement that AIRAProstate and AIRAQc are being integrated into Fusion AP, with attention to workflow,…
AstraZeneca and Roche in Asia: why this matters to pathologists before it matters to digital pathology platforms
The AstraZeneca-Roche agreement in Asia focuses on digital pathology and AI for HER2 and TROP2, with practical implications for pathologists.